Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

SELF-TEST FOR GLUCOSE - ANVISA Registration 10410130049

Access comprehensive regulatory information for SELF-TEST FOR GLUCOSE in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10410130049 and manufactured by BIOLAND TECHNOLOGY LTD. The registration is held by CONTROLLER COMÉRCIO E SERVIÇOS LTDA with validity until May 30, 2032.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 companies making the same product including OK BIOTECH CO., LTD., ROCHE DIABETES CARE GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
10410130049
2 Related Devices
Registration Details
ANVISA Registration Number: 10410130049
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Related Devices (2)

SOLUÇÃO DE CONTROLE DE GLICOSE BIOLAND
Risk Class III

Registration Details

10410130049

25351026544202266

78515210000100

Company Information

China
PT: CHINA, REPÚBLICA POPULAR

Dates and Status

May 30, 2022

30/05/2032

09/18/2025 19:00:01

SOLUÇÃO DE CONTROLE DE GLICOSE BIOLAND
Risk Class III

Registration Details

10410130049

25351026544202266

78515210000100

Company Information

Dates and Status

May 30, 2022

30/05/2032

09/18/2025 19:00:01